Collectively, the apparent lack of effect on BP of acute and steady state inhibition of central AT1 receptors and acute ROS inhibition, suggests that overactivity of central AT1 receptor or associated ROS signaling are unlikely to be contributing to high BP in this model of hypertension. This evidence concerns the gene AGTR1 and Hypertension.